Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
ESMO Open|June 27, 2021
Trifluridine/tipiracil versus placebo for third or later lines of treatment in metastatic gastric cancer: an exploratory subgroup analysis from the TAGS studyJ Tabernero, K Shitara, A Zaanan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 9, 2022
Streamlining clinical research: an ESMO awareness call to improve sponsoring and monitoring of clinical trialsJ L Perez-Gracia, N Penel, E Calvo, et al.
ESMO Open|June 2, 2022
Quality of life with encorafenib plus cetuximab with or without binimetinib treatment in patients with BRAF V600E-mutant metastatic colorectal cancer: patient-reported outcomes from BEACON CRCS Kopetz, A Grothey, E Van Cutsem, et al.
European Journal of Cancer (Oxford, England : 1990)|September 10, 2018
An extended phase Ib study of epertinib, an orally active reversible dual EGFR/HER2 tyrosine kinase inhibitor, in patients with solid tumoursH-T Arkenau, A Italiano, G Mak, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 13, 2008
Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experienceD Olmos, H-T Arkenau, J E Ang, et al.
British Journal of Cancer|August 23, 2012
Prediction of early death among patients enrolled in phase I trials: development and validation of a new model based on platelet count and albuminA Ploquin, D Olmos, D Lacombe, et al.
British Journal of Cancer|July 15, 2010
The insulin-like growth factor-I receptor inhibitor figitumumab (CP-751,871) in combination with docetaxel in patients with advanced solid tumours: results of a phase Ib dose-escalation, open-label studyL R Molife, P C Fong, L Paccagnella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 28, 2016
Systematic evaluation of pembrolizumab dosing in patients with advanced non-small-cell lung cancerM Chatterjee, D C Turner, E Felip, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 14, 2016
A phase I, pharmacokinetic and pharmacodynamic study of GSK2256098, a focal adhesion kinase inhibitor, in patients with advanced solid tumorsJ C Soria, H K Gan, S P Blagden, et al.
Pageof 3